Conor McNamara
Stock Analyst at RBC Capital
(0)
# 4358
Out of 5,240 analysts
93
Total ratings
27.63%
Success rate
-11.13%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Bio-Rad Laboratories | Reiterates: Outperform | 481 481 | 345.85 | 39.08% | 10 | Jan 14, 2025 | |
Maravai LifeSciences | Maintains: Outperform | 17 13 | 4.71 | 176.01% | 6 | Nov 8, 2024 | |
Hologic | Maintains: Sector Perform | 86 89 | 70.09 | 26.98% | 8 | Nov 5, 2024 | |
Illumina | Maintains: Outperform | 252 254 | 138.78 | 83.02% | 12 | Nov 5, 2024 | |
Thermo Fisher Scient... | Maintains: Outperform | 767 718 | 560.54 | 28.09% | 13 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 333 311 | 240.31 | 29.42% | 7 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 205 205 | 158 | 29.75% | 9 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 34 34 | 21.75 | 56.32% | 5 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 61 61 | 41.66 | 46.42% | 10 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 7 7 | 3.32 | 110.84% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Perform | 72 70 | 76.65 | -8.68% | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 8 7 | 3.23 | 116.72% | 4 | Aug 7, 2024 |